For the period of 10 to 16 September 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 10 – 16 September 2022 Document Preview:
[Advisory] Draft Department Memorandum on the Methodology of PEMDL Draft Interim Guidelines on the Process and Methods for the Selection of Medical Devices for Inclusion in the Philippine Essential Medical Device List (PEMDL) for Comments until 21 September 2022
Stakeholders may submit comments to the draft interim guidelines and/or the draft initial Philippine Essential Medical Device List (PEMDL) to hta@doh.gov.ph/mdu@doh.gov.ph until 04 November 2022. Document Preview (Advisory and Draft Interim Guidelines): Draft Department Memorandum for comments: Click here for the editable version of the document.
Evidence brief for 03 to 09 September 2022
For the period of 03 to 09 September 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 03 to 09 September 2022
HTAC Preliminary Recommendation for Government Financing of Zoledronic Acid for Individuals with Malignancy-Related Bone Disease
Link to evidence summary Publication date: 07 September 2022 (Stakeholders may submit appeals to hta@doh.gov.ph until 22 September 2022 using the prescribe form found here: Topic Nomination ) Document Preview:
Evidence brief for 27 August to 02 September 2022
For the period of 27 August 2022 to 02 September 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 27 August to 02 September 2022